Nanology Labs is a biotechnology company focused on advancing the development of T-MX, a first-in-class nanomedicine that can overcome cancer cells' treatment-resistance and improve therapeutic outcomes in the treatment of solid tumor cancers, leading to better survival and quality of life. The company also pursues collaborations with strategic partners to develop new precision medicines enabled by its proprietary drug delivery platform technology (TERP), which has a high degree of payload and targeting flexibility, with intrinsic capability for active transport into cells and across the blood-brain-barrier.